Xifeng Dong

871 total citations
46 papers, 619 citations indexed

About

Xifeng Dong is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Xifeng Dong has authored 46 papers receiving a total of 619 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 11 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in Xifeng Dong's work include Lung Cancer Treatments and Mutations (5 papers), Multiple Myeloma Research and Treatments (4 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Xifeng Dong is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Multiple Myeloma Research and Treatments (4 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Xifeng Dong collaborates with scholars based in China, United States and Ethiopia. Xifeng Dong's co-authors include Weisan Zhang, Qian Liu, Qin Ning, Xiaoping Luo, Ping Lei, Wendong Zhang, Ping Lei, Shuo Chen, K.L. Yao and Wenjun Xia and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Physical Review B.

In The Last Decade

Xifeng Dong

42 papers receiving 610 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xifeng Dong China 13 209 194 75 71 54 46 619
Haiyan Ge China 14 239 1.1× 135 0.7× 117 1.6× 62 0.9× 53 1.0× 30 501
Bárbara Cardinali Italy 15 191 0.9× 155 0.8× 56 0.7× 67 0.9× 48 0.9× 28 470
Andrew Dang United States 11 185 0.9× 110 0.6× 75 1.0× 72 1.0× 81 1.5× 23 463
Kejia Zhao China 14 249 1.2× 145 0.7× 45 0.6× 95 1.3× 25 0.5× 35 579
Marie Müller France 12 265 1.3× 173 0.9× 91 1.2× 148 2.1× 20 0.4× 30 546
Stephanie T. Murphy United States 14 251 1.2× 89 0.5× 102 1.4× 107 1.5× 54 1.0× 22 729
Aoyu Li China 11 244 1.2× 109 0.6× 131 1.7× 48 0.7× 46 0.9× 27 464
Rosangela A.M. Wailemann Brazil 7 174 0.8× 163 0.8× 59 0.8× 61 0.9× 55 1.0× 13 476
Manman Xu China 16 214 1.0× 112 0.6× 122 1.6× 90 1.3× 50 0.9× 72 701
Xin Xia China 16 317 1.5× 161 0.8× 170 2.3× 143 2.0× 22 0.4× 55 697

Countries citing papers authored by Xifeng Dong

Since Specialization
Citations

This map shows the geographic impact of Xifeng Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xifeng Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xifeng Dong more than expected).

Fields of papers citing papers by Xifeng Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xifeng Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xifeng Dong. The network helps show where Xifeng Dong may publish in the future.

Co-authorship network of co-authors of Xifeng Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Xifeng Dong. A scholar is included among the top collaborators of Xifeng Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xifeng Dong. Xifeng Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Huiqin, Yumei Liu, Liyan Yang, et al.. (2025). Aberrant Hematopoiesis and CD8+ T‐Cell Activation in Thymoma‐Associated Pure Red Cell Aplasia. Thoracic Cancer. 16(6). e70046–e70046. 1 indexed citations
2.
Song, Jian H., Ping Zhou, Ruizhe Qian, et al.. (2025). Targeting both wild-type EGFR and its drug-resistant mutants with erlotinib-aptamer conjugates. European Journal of Medicinal Chemistry. 296. 117871–117871.
3.
4.
Tian, Xiaoyu, Kaiyue Zhang, Xifeng Dong, et al.. (2024). Primary cilia restrict autoinflammation by mediating PD-L1 expression. Science Bulletin. 69(16). 2505–2508. 2 indexed citations
5.
Ni, Hua, Miao Chen, Dan Dong, et al.. (2024). CYLD/HDAC6 signaling regulates the interplay between epithelial-mesenchymal transition and ciliary homeostasis during pulmonary fibrosis. Cell Death and Disease. 15(8). 581–581. 6 indexed citations
6.
Li, Xinlu, Xifeng Dong, Wen Zhang, et al.. (2024). Multi-omics in exploring the pathophysiology of diabetic retinopathy. Frontiers in Cell and Developmental Biology. 12. 1500474–1500474. 2 indexed citations
7.
Zhang, Mingjie, Gaochao Zhang, Mengyuan Liu, et al.. (2023). Identification of Plasma Thrombopoietin Level and Its Significance in Patients with Aplastic Anemia and Myelodysplastic Syndrome. SHILAP Revista de lepidopterología. 10(3). 194–198. 2 indexed citations
8.
Zhang, Yue, Xifeng Dong, & Huaquan Wang. (2023). VEXAS Syndrome—Review. SHILAP Revista de lepidopterología. 10(3). 133–143. 13 indexed citations
9.
Zhang, Weisan & Xifeng Dong. (2021). Positive progress for non-small cell lung cancer with epidermal growth factor receptor exon 20 insertion mutations: A novel targeted therapy option. Journal of Oncology Pharmacy Practice. 27(8). 2007–2009. 3 indexed citations
10.
11.
Dong, Xifeng, et al.. (2021). Primary mediastinal large B cell lymphoma. Thoracic Cancer. 12(21). 2831–2837. 8 indexed citations
12.
Liu, Qian & Xifeng Dong. (2021). Targeting De Novo Lipogenesis and Cholesterol Biosynthesis Simultaneously is a Novel Therapeutic Option for Hepatocellular Carcinoma. SHILAP Revista de lepidopterología. Volume 8. 19–21. 3 indexed citations
13.
Li, Chenyuan, Xifeng Dong, Huaquan Wang, & Zonghong Shao. (2021). The Role of T Lymphocytes in the Pathogenesis of Paroxysmal Nocturnal Hemoglobinuria. Frontiers in Immunology. 12. 777649–777649. 4 indexed citations
14.
Dong, Xifeng, et al.. (2014). The new concepts on overcoming drug resistance in lung cancer. Drug Design Development and Therapy. 8. 735–735. 31 indexed citations
15.
Zhang, Wendong, et al.. (2014). Advances in tumor markers of ovarian cancer for early diagnosis. Indian Journal of Cancer. 51(7). 72–72. 74 indexed citations
16.
Dong, Xifeng, et al.. (2013). Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration in the Mediastinal Staging of Non-Small Cell Lung Cancer: A Meta-Analysis. The Annals of Thoracic Surgery. 96(4). 1502–1507. 81 indexed citations
17.
18.
19.
Zhang, Jing, et al.. (2009). Ginsenoside Rg3 promotes beta-amyloid peptide degradation by enhancing gene expression of neprilysin. Journal of Pharmacy and Pharmacology. 61(3). 375–380. 25 indexed citations
20.
Dong, Xifeng, et al.. (2007). The detection of HBV DNA with gold-coated iron oxide nanoparticle gene probes. Journal of Nanoparticle Research. 10(3). 393–400. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Haiyan Ge Breakdown of academic impact, for papers by Bárbara Cardinali Breakdown of academic impact, for papers by Andrew Dang Breakdown of academic impact, for papers by Kejia Zhao Breakdown of academic impact, for papers by Marie Müller Breakdown of academic impact, for papers by Stephanie T. Murphy Breakdown of academic impact, for papers by Aoyu Li Breakdown of academic impact, for papers by Rosangela A.M. Wailemann Breakdown of academic impact, for papers by Manman Xu Breakdown of academic impact, for papers by Xin Xia
Rankless by CCL
2026